Abstract
Higher Serum IL-8 is associated with Reduced PFS and OS during Systemic Therapy in Metastatic Breast, Pancreatic and Prostate Cancer: A Retrospective Study in Patients from BOLERO-2 Trial, Pancreatic and Prostate Cancer Cohorts
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
